NM_000130.5:c.6193+831G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000130.5(F5):​c.6193+831G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.496 in 152,020 control chromosomes in the GnomAD database, including 19,202 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.50 ( 19202 hom., cov: 32)

Consequence

F5
NM_000130.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.82

Publications

6 publications found
Variant links:
Genes affected
F5 (HGNC:3542): (coagulation factor V) This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance. [provided by RefSeq, Oct 2008]
F5 Gene-Disease associations (from GenCC):
  • thrombophilia due to activated protein C resistance
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • congenital factor V deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • East Texas bleeding disorder
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-169519689-C-T is Benign according to our data. Variant chr1-169519689-C-T is described in ClinVar as Benign. ClinVar VariationId is 1599739.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.656 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F5NM_000130.5 linkc.6193+831G>A intron_variant Intron 22 of 24 ENST00000367797.9 NP_000121.2 P12259

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F5ENST00000367797.9 linkc.6193+831G>A intron_variant Intron 22 of 24 1 NM_000130.5 ENSP00000356771.3 P12259
F5ENST00000367796.3 linkc.6208+831G>A intron_variant Intron 22 of 24 5 ENSP00000356770.3 A0A0A0MRJ7

Frequencies

GnomAD3 genomes
AF:
0.496
AC:
75401
AN:
151902
Hom.:
19204
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.419
Gnomad AMI
AF:
0.663
Gnomad AMR
AF:
0.402
Gnomad ASJ
AF:
0.483
Gnomad EAS
AF:
0.675
Gnomad SAS
AF:
0.437
Gnomad FIN
AF:
0.613
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.536
Gnomad OTH
AF:
0.479
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.496
AC:
75425
AN:
152020
Hom.:
19202
Cov.:
32
AF XY:
0.496
AC XY:
36882
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.419
AC:
17362
AN:
41444
American (AMR)
AF:
0.402
AC:
6137
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.483
AC:
1675
AN:
3470
East Asian (EAS)
AF:
0.675
AC:
3489
AN:
5170
South Asian (SAS)
AF:
0.438
AC:
2106
AN:
4812
European-Finnish (FIN)
AF:
0.613
AC:
6471
AN:
10562
Middle Eastern (MID)
AF:
0.415
AC:
122
AN:
294
European-Non Finnish (NFE)
AF:
0.536
AC:
36444
AN:
67964
Other (OTH)
AF:
0.480
AC:
1014
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1934
3869
5803
7738
9672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.508
Hom.:
28310
Bravo
AF:
0.481
Asia WGS
AF:
0.518
AC:
1800
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Congenital factor V deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.21
DANN
Benign
0.36
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3766103; hg19: chr1-169488927; API